Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shot up 37.5% on Thursday . The stock traded as high as GBX 24 ($0.29) and last traded at GBX 22 ($0.27). 369,955 shares changed hands during trading, an increase of 231% from the average session volume of 111,807 shares. The stock had previously closed at GBX 16 ($0.19).
Celadon Pharmaceuticals Stock Down 29.7 %
The company has a quick ratio of 6.97, a current ratio of 1.92 and a debt-to-equity ratio of 194.82. The company has a market cap of £15.49 million, a price-to-earnings ratio of -281.25 and a beta of -0.26. The business has a 50-day simple moving average of GBX 17.69 and a two-hundred day simple moving average of GBX 33.37.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- What is the MACD Indicator and How to Use it in Your Trading
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Low PE Growth Stocks: Unlocking Investment Opportunities
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Expert Stock Trading Psychology Tips
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
